T

Reporters learned from Harbin Institute of Technology that Professor Huang Zhiwei's team from the Faculty of Life Sciences and Medicine has made a research breakthrough, discovering a new type of antibody named "4B1" that can efficiently activate T cells to kill tumors while only causing very low levels of inflammation factor release. This achievement provides a new approach for the development of both effective and safe next-generation anti-cancer drugs, and the related paper was published in the international academic journal "Vita" on June 2nd.